CN105596432A - Application of jasminum cinnamomifolium kobuski extract in preparation of medicine resisting free radical oxidation damage of cardiac muscle cells - Google Patents

Application of jasminum cinnamomifolium kobuski extract in preparation of medicine resisting free radical oxidation damage of cardiac muscle cells Download PDF

Info

Publication number
CN105596432A
CN105596432A CN201610075451.0A CN201610075451A CN105596432A CN 105596432 A CN105596432 A CN 105596432A CN 201610075451 A CN201610075451 A CN 201610075451A CN 105596432 A CN105596432 A CN 105596432A
Authority
CN
China
Prior art keywords
spun gold
extract
medicine
boisiana extract
myocardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610075451.0A
Other languages
Chinese (zh)
Inventor
刘学键
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Huazhicao Medical Technology Co Ltd
Original Assignee
Qingdao Huazhicao Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Huazhicao Medical Technology Co Ltd filed Critical Qingdao Huazhicao Medical Technology Co Ltd
Publication of CN105596432A publication Critical patent/CN105596432A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses an application of a jasminum cinnamomifolium kobuski extract in preparation of a medicine resisting free radical oxidation damage of cardiac muscle cells. The jasminum cinnamomifolium kobuski extract serving as an active ingredient can improve the T wave of the ST segment of a patient suffering from acute myocardial ischemia and also can resist the free radical oxidation damage of cardiac muscle cells and enhance the energy supply of the body so as to achieve an aim of treating myocardial ischemia.

Description

The purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury
The application is the divisional application of the application for a patent for invention that proposes of applicant Wang Xueyan (denomination of invention is: a kind of medical composition and its use resisting myocardial ischemia, application number is: 2014103651409, the applying date is: on July 29th, 2014).
Technical field
The invention belongs to Chinese medicine extractive technique field, the purposes in particular to a kind of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury.
Background technology
Myocardial ischemia refers to that the hemoperfusion of heart reduces, and causes the oxygen supply of heart to reduce, and energy metabolism of myocardial is undesired, can not support a kind of pathological state of the normal work of heart. Interrelated data demonstration, myocardial ischemia mostly occurred after 40 years old, and average illness rate is about 6.49%. Along with the raising of living standards of the people, myocardial ischemia is the trend rising year by year in the illness rate of China at present, and morbidity crowd rejuvenation trend is obvious. Myocardial ischemia is also one of disease kind that the death rate is the highest, is common in acute sudden death, myocardial infarction etc. Modern medicine is thought, the common reason of myocardial ischemia is coronary atherosclerosis, secondly also has inflammation (rheumatic, syphilis, Kawasaki disease and thromboangitis obliterans etc.), spasm, embolism, connective tissue disease, wound and congenital abnormality etc. multiple.
Doctor trained in Western medicine has medicine treatment to this sick methods for the treatment of, and as antiplatelet drug, receptor blocking agent, calcium ion antagonist, statins, nitric acid lipid drug, thrombolysis class medicine etc., its curative effect is all not ideal, only only alleviate, and side effect is larger. Take stopgap measures and be difficult to effect a permanent cure in view of western medical treatment is limited to, even if comparatively winner of PCI and operative treatment, be also difficult to multiple to patient with healthy physique, the traditional Chinese medicine of therefore finding many target treatments seems particularly urgent.
Spun gold Calamus is in climbing shrub, high 1-4m. Complete stool unit hair. Cylindrical or the tool rill of sprig, footpath 1-2mm. Leaf is to life, Dan Ye; The long 4-10mm of petiole, reverses, and has joint; Blade papery or thin keratin, oval or narrow ellipse, rare by aciculiform, long 5-10.5cm, wide 1.5-4.5cm, the sharp point of tip is point extremely gradually, base portion wedge shape or circle, leaf margin warp, base goes out 5, arteries and veins, and 1 pair, outside is not obvious, upwards extends through top, and is connected with transverse vein. Flower Dan Sheng, or be umbrella cyme, top is raw or armpit is raw, has colored 1-5 piece; Inflorescence is without stalk or the long 0.2-2cm of stalk; Bract is linear, long 2-4mm; Bennet is elongated, and long 1.4-2.5cm is upwards cumulative thick; Calyx pipe range 2-3mm, 5 pieces of slivers, sharp triangle, long 1-2mm; Corolla white, high pin dish shape, corolla pipe range 0.9-1.3cm, footpath 1-2mm, sliver 9-11 piece, lanceolar, long 1.1-2cm, wide 1.5-3mm, tip is point gradually. Fruit is spherical or oval, long 1-1.5cm, and footpath 0.8-1.5cm, is black. The florescence 3-9 month, the fruit phase 5-11 month. Be born in woods or sand ground. Be distributed in Hainan, Yunnan.
At present, spun gold rattan is in the news and has clearing heat and detoxicating, synthetism is cured the wound effect as Chinese medicine, be mainly used in controlling abscess of throat, pathopyretic ulcer, fracture and traumatism and bleeding, there is no bibliographical information spun gold rattan or its extract and there is the biologically active that strengthens acute myocardial ischemia patient cardiac muscle energy supply or anti-myocardial and be subject to Free radicals injury.
Summary of the invention
The object of the invention is to by secret prescription handed down in the family from generation to generation is furtherd investigate, thereby a kind of pharmaceutical composition resisting myocardial ischemia is provided, a kind of pharmaceutical composition of anti-acute myocardial ischemia is especially provided. This spun gold boisiana extract can be developed into the pharmaceutical preparation of the disease due to the myocardial ischemias such as treatment coronary heart diseases and angina pectoris.
Particularly, the object of the invention is to adopt following technical scheme to realize:
The pharmaceutical composition resisting myocardial ischemia, is prepared from by acceptable auxiliary material in active component and pharmacy, it is characterized in that, described active component comprises spun gold boisiana extract.
Preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, described spun gold boisiana extract is prepared from by the following method: get spun gold rattan raw material, add aqueous sodium carbonate refluxing extraction, extract regulates pH=2.8-3.2 with hydrochloric acid, leave standstill, filter, get precipitation and be dried, obtain spun gold boisiana extract.
Further preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, the concentration of described aqueous sodium carbonate is 3%-10%.
Again further preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, the concentration of described aqueous sodium carbonate is 4%-7%.
Again further preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, the 8-15 that the consumption of described aqueous sodium carbonate is raw material weight is doubly.
Further preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, the number of times of described refluxing extraction is 1-4 time, boils 2-4h at every turn.
Further preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, described extract regulates pH=3.0 by acid solution.
Further preferably, the pharmaceutical composition resisting myocardial ischemia as mentioned above, wherein, the time of described standing step is 4-24h.
It should be noted that the tender leaf of the spun gold rattan raw material choose Oleaceae plants leaf of cinnamomi Jasmine JasminumcinnamomifoliumKobuski that the present invention adopts in the time of the described spun gold boisiana extract of preparation. Can select the dry product drying, also can select fresh wet product.
The inventor causes that by lumbar injection Pit coronarospasm is to copy Model Rats with Acute Myocardial Ischemia. Pit extracts the material obtaining from animal pituitary, contain pitressin (antidiuretin) and oxytocins, pitressin can directly make blood vessel, particularly capillary and parteriole shrink, thereby can make coronarospasm, contraction make myocardial ischemia-anoxemia. Therefore, the Model Rats with Acute Myocardial Ischemia that the present invention copies occurs that abnormal electrocardiographic pattern changes, and is mainly reflected in ST section, T ripple is abnormal. Carry out therapeutic intervention discovery by giving spun gold boisiana extract, spun gold boisiana extract can improve rat model electrocardiographic abnormality situation, to play protection Myocardial Effects. In addition, in acute myocardial ischemia process, ultra-oxygen anion free radical (O2 -) a large amount of formation and the increase of lipid peroxidation be one of main pathologic process of cellular damage. SOD is extensively present in organism and the closely-related protein of cell oxygen metabolism, highly in specific manner the catalysis O harmful to body2 -Disproportionated reaction, and get rid of O2 -To the infringement of body cell, tissue, the damage of antagonism ischemic hypoxia disease, hypoxic-ischemic again perfused tissue damage have important protective effect. MDA is the stable metabolin of peroxidatic reaction of lipid, measure MDA content can reflecting myocardium tissue in O2 -Content and the peroxidatic reaction of lipid degree of initiation, indirectly reflect that cell is subject to the degree of Free radicals injury. The present invention shows by above-mentioned experimental study, and spun gold boisiana extract can significantly strengthen model rat heart muscle SOD activity, reduces MDA content, thus protection damaged myocardium. Moreover ATP is a kind of coenzyme, participate in the metabolism such as body protein, fat, sugar, nucleic acid, nucleotides, be again the main source of human body energy, its metabolic disorder can reflect that body energy supply is abnormal. The present invention shows by above-mentioned experimental study, and spun gold boisiana extract can significantly strengthen model rat heart muscle ATP content, thereby ensures the energy supply abundance of damaged myocardium. In sum, spun gold boisiana extract can play a protective role to Model of Acute Myocardial Ischemia rat, and it is machine-processed and improve heart ST section, T ripple and anti-oxidant, strengthens body energy supply relevant.
Based on above-mentioned result of study, another object of the present invention is to provide a kind of pharmaceutical applications, that is: the purposes in the medicine that above-mentioned spun gold boisiana extract resists myocardial ischemia in preparation. Or: above-mentioned spun gold boisiana extract improves the purposes in the medicine of acute myocardial ischemia patient electrocardiographic abnormality in preparation; The purposes of above-mentioned spun gold boisiana extract in the medicine of preparation enhancing acute myocardial ischemia patient cardiac muscle energy supply; The purposes of above-mentioned spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury.
Compared with prior art, the pharmaceutical composition the present invention relates to is prepared from as unique raw material by spun gold rattan, contained spun gold boisiana extract can improve acute myocardial ischemia patient's heart ST section, T ripple as active component, can be subject to Free radicals injury by anti-myocardial simultaneously, strengthen body energy supply, thereby reach the therapeutic purposes of the myocardial ischemia such as resisting coronary heart disease, angina pectoris disease.
Detailed description of the invention
Be below Preparation Example and the effect test example of spun gold boisiana extract of the present invention, the present invention will be further described and explanation. It should be noted that the dry tender leaf of the spun gold rattan raw material choose Oleaceae plants leaf of cinnamomi Jasmine JasminumcinnamomifoliumKobuski that following examples adopt in the time of the described spun gold boisiana extract of preparation.
The preparation of embodiment 1 spun gold boisiana extract
Take dry spun gold rattan 850g, impurity elimination, adds 10L mass percentage concentration and is 5% sodium carbonate liquor, soak 40min, refluxing extraction 2 times is boiled 3h at every turn, filter, merging filtrate, regulates filtrate pH=3.0 with concentrated hydrochloric acid, normal temperature hold over night, filters, and gets precipitation, dry, pulverize, cross 100 mesh sieves, obtain spun gold boisiana extract dry powder.
The affect experimental study of embodiment 2 spun gold boisiana extracts on Model of Acute Myocardial Ischemia rat
60 of clean level SD rats, male, body weight 150~180g, experiment is divided into following five groups, be Normal group (wait and hold physiological saline), model control group (wait and hold physiological saline), ISDN (15mg/kg) and spun gold boisiana extract high and low dose (spun gold boisiana extract dry powder 180,60mg/kg prepared by embodiment 1) group, 12 every group. Gastric infusion, every day 1 time, 15d continuously, 1h after last administration, except Normal group, all the other respectively organize lumbar injection Pit (20U/kg) to copy Acute Myocardial Ischemia Rats model.
After last administration 1h, lumbar injection 3% yellow Jackets (1mL/kg) anesthesia rats in normal control group, back of the body position is fixing, and the needle electrode of polygraph inserts respectively subcutaneous, and first Continuous Observation also records one section of normal ECG; After reconstructed model, detect all the other each group Rat Ecg ST section and T ripples. Then put to death rat, get each group of rat cardiac ventricular flesh, homogenate in frozen water, the centrifugal 5min of l000r/min, gets supernatant as sample. With TBA method thought-read flesh MDA content, by pyrogallol method survey SOD activity. Separately get each group of rat cardiac ventricular flesh and shred, the cooling lower pulverize of nitrogen, adds 1mL acetone immediately after weighing, and room temperature is placed 15min, and in 90 DEG C of water-baths, about 4min volatilizes acetone, adds 5mL2mmol/LMgSO4, cooling after boiling water boiling 15min, the centrifugal 10min of 1000r/min, gets supernatant as sample, by the content of biloluminescence method working sample ATP.
The demonstration of detecting ECG result, with Normal group comparison, model group Rat Ecg ST section is obviously raised, and T wave height point obviously, shows that Model of Acute Myocardial Ischemia copies successfully; Spun gold boisiana extract high dose group Rat Ecg ST section is slightly raised, and low dose group Rat Ecg ST section is obviously raised, and shows that high dose spun gold boisiana extract is improved effect to rat model ECG ST section.
The impact of spun gold boisiana extract active on rat model SOD of heart tissue in MDA content is in Table l. Result of the test by table 1 can find out, with Normal group comparison, model control group rat heart muscle SOD activity significantly weakens, MDA content significantly raise (P< 0.01), show that rat heart muscle oxidation resistance weakens. With model control group comparison, spun gold boisiana extract high and low dose group rat heart muscle SOD is active significantly to be strengthened (P< 0.01), MDA content significantly reduce (P< 0.01 orP< 0.05). This result shows that spun gold boisiana extract has certain antioxidation, and is dose-effect relationship.
Table l respectively organizes rat heart muscle SOD activity and the comparison of MDA content
Model control group and Normal group comparison, P<0.05,●● P<0.01;
Treatment group and model control group comparison, P<0.05,★★ P<0.01。
Spun gold boisiana extract on the impact of rat model myocardium ATP content in table 2. Result of the test by table 2 can find out, with Normal group comparison, model control group rat heart muscle ATP content significantly reduce (P< 0.01), show that rat heart muscle energy supply is abnormal. With model group comparison, spun gold boisiana extract high and low dose group rat heart muscle ATP content significantly raise (P< 0.01 orP< 0.05). This result shows that spun gold boisiana extract has the abnormal effect of the myocardium energy supply of certain improvement, and is dose-effect relationship.
The comparison of the each group of table 2 rat heart muscle ATP content
Model control group and Normal group comparison, P<0.05,●● P<0.01;
Treatment group and model control group comparison, P<0.05,★★ P<0.01。

Claims (7)

1. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury, it is characterized in that: described spun gold boisiana extract is prepared from by the following method: get spun gold rattan raw material, add aqueous sodium carbonate refluxing extraction, extract regulates pH=2.8-3.2 with hydrochloric acid, leave standstill, filter, get precipitation and be dried, obtain spun gold boisiana extract;
The dry tender leaf of described spun gold rattan raw material choose Oleaceae plants leaf of cinnamomi Jasmine JasminumcinnamomifoliumKobuski.
2. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury according to claim 1, is characterized in that: the concentration of described aqueous sodium carbonate is 3%-10%.
3. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury according to claim 2, is characterized in that: the concentration of described aqueous sodium carbonate is 4%-7%.
4. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury according to claim 3, is characterized in that: the 8-15 that the consumption of described aqueous sodium carbonate is raw material weight doubly.
5. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury according to claim 1, is characterized in that: the number of times of described refluxing extraction is 1-4 time, boils 2-4h at every turn.
6. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury according to claim 1, is characterized in that: described extract acid solution regulates pH=3.0.
7. the purposes of spun gold boisiana extract in the medicine of preparing anti-myocardial and be subject to Free radicals injury according to claim 1, is characterized in that: the time of described standing step is 4-24h.
CN201610075451.0A 2014-07-29 2014-07-29 Application of jasminum cinnamomifolium kobuski extract in preparation of medicine resisting free radical oxidation damage of cardiac muscle cells Withdrawn CN105596432A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410365140.9A CN104083444B (en) 2014-07-29 2014-07-29 A kind of medical composition and its use resisted myocardial ischemia

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201410365140.9A Division CN104083444B (en) 2014-07-29 2014-07-29 A kind of medical composition and its use resisted myocardial ischemia

Publications (1)

Publication Number Publication Date
CN105596432A true CN105596432A (en) 2016-05-25

Family

ID=51631272

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201610075413.5A Withdrawn CN105596431A (en) 2014-07-29 2014-07-29 Application of jasminum cinnamomifolium kobuski extract in preparation of medicine improving electrocardiographic abnormality of patient suffering from acute myocardial ischemia
CN201410365140.9A Active CN104083444B (en) 2014-07-29 2014-07-29 A kind of medical composition and its use resisted myocardial ischemia
CN201610075451.0A Withdrawn CN105596432A (en) 2014-07-29 2014-07-29 Application of jasminum cinnamomifolium kobuski extract in preparation of medicine resisting free radical oxidation damage of cardiac muscle cells

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CN201610075413.5A Withdrawn CN105596431A (en) 2014-07-29 2014-07-29 Application of jasminum cinnamomifolium kobuski extract in preparation of medicine improving electrocardiographic abnormality of patient suffering from acute myocardial ischemia
CN201410365140.9A Active CN104083444B (en) 2014-07-29 2014-07-29 A kind of medical composition and its use resisted myocardial ischemia

Country Status (1)

Country Link
CN (3) CN105596431A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050142229A1 (en) * 2003-12-29 2005-06-30 Jiao Gong Pharmaceutical activity and manufacturing method of the four-plant-derived coronary blood flow enhancing agent
CN1813902A (en) * 2005-12-02 2006-08-09 蓝子花 Salacia medicinal liquor for dispelling wetness-evil and stopping pain

Also Published As

Publication number Publication date
CN104083444B (en) 2016-04-13
CN105596431A (en) 2016-05-25
CN104083444A (en) 2014-10-08

Similar Documents

Publication Publication Date Title
CN103446385B (en) Traditional Chinese medicine preparation for treating diabetic complications
CN102861287B (en) Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof
CN105596705A (en) Application of traditional Chinese medicine composition in preparation of medicine for treating cerebral thrombosis
CN102302552A (en) Capsules for treating arrhythmia and preparation method thereof
CN103784934B (en) A kind of pharmaceutical composition and application thereof preventing and treating acute myocardial infarction
CN105833229A (en) Application of traditional Chinese medicine composition in preparation of medicine for treating myocardial infarction
CN104083444B (en) A kind of medical composition and its use resisted myocardial ischemia
CN104970223A (en) Compound feed for cattle and preparation method of compound feed
CN109248177A (en) The preparation of crocodile first active principle and its anti-oxidant, anti-hepatic fibrosis application
CN103549072B (en) Vital energy-benefiting brain-boosting tea and preparation method thereof
CN100430079C (en) Chinese medicine for treating heart disease
CN104138566A (en) Medicine for treating angina pectoris heart blood stasis type coronary heart disease
CN104256618B (en) A kind of hypoglycemic food, health products or pharmaceutical composition
CN105708905A (en) Application of jasminum cinnamomifolium extract in preparing drug for enhancing cardiac muscle energy supply of patient with acute myocardial ischemia
CN105663252A (en) Application of Jasminum cinnamomifolium Kobuski extract in preparation of anti-myocardial ischemia medicine
CN105663370A (en) Externally-used medicine for treating verruca plantaris
CN104622987B (en) A kind of pharmaceutical composition for treating chronic hepatitis liver cirrhosis and application
CN110841037B (en) Traditional Chinese medicine medicament for treating circadian rhythm disorder sleep disorder and preparation method thereof
CN104435865B (en) Traditional Chinese medicine for treating arrhythmia and preparation method thereof
CN109568481A (en) A kind of Chinese prescription preparation for treating coronary heart disease
KR101611966B1 (en) Production of antlers and medicinal herbs extract for arthritis care medicine
CN115531459B (en) Application of Jingfeng particles in preparing medicament for preventing or treating myocardial infarction
CN102949466A (en) Foot bathing liquid for yang promotion and solid doff
CN105641016A (en) Pharmaceutical composition for treating coronary heart disease
CN105031286A (en) Chinese herb preparation for treating iron-deficiency anemia and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: You Fuli

Inventor after: Liu Xuejian

Inventor before: Liu Xuejian

WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20160525